ArticleCancers2025

Distinct NF-kB Regulation Favors a Synergic Action of Pevonedistat and Laduviglusib in B-Chronic Lymphocytic Leukemia Cells Ex Vivo.

Víctor Arenas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.